Alzamend Neuro, Inc. (ALZN) › Shareholders' EquityAlzamend Neuro, Inc. (ALZN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $316.9K2020: $821.7K2021: $2.01M2022: $13.35M2023: $3.05M2024: -$2.59M2025: $3.97M2026: $733.2K$733.2K2019Shareholders' Equity (USD)2026Fiscal YearShareholders' EquityChange YoY2026$733.2K-81.5%2025$3.97M+253.0%2024-$2.59M-185.2%2023$3.05M-77.2%2022$13.35M+563.3%2021$2.01M+145.0%2020$821.7K+159.3%2019$316.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share